International Journal of Radiation Oncology * Biology * Physics
Volume 48, Issue 4 , Pages 977-982 , 1 November 2000

A cost-outcome analysis of adjuvant postmastectomy locoregional radiotherapy in premenopausal node-positive breast cancer patients

Presented at the 41st Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Antonio, TX (USA), October 31–November 4, 1999.

  • Peter Dunscombe, Ph.D.

      Affiliations

    • Northeastern Ontario Regional Cancer Centre, Sudbury, Ontario, Canada
    • University of Ottawa, Ottawa, Ontario, Canada
    • Laurentian University, Sudbury, Ontario, Canada
    • Corresponding Author InformationReprint requests to: Dr. Peter Dunscombe, Northeastern Ontario Regional Cancer Centre, 41 Ramsey Lake Road, Sudbury, Ontario, Canada P3E 5J1
  • ,
  • Rajiv Samant, M.D.

      Affiliations

    • Northeastern Ontario Regional Cancer Centre, Sudbury, Ontario, Canada
    • University of Ottawa, Ottawa, Ontario, Canada
  • ,
  • Gisele Roberts (M.B.A.)

      Affiliations

    • Northeastern Ontario Regional Cancer Centre, Sudbury, Ontario, Canada

,Accepted 27 April 2000.

References 

  1. Cuzick J, Stewart H, Rutqvist L, et al.  Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol. 1994;12(3):447–453
  2. Early Breast Cancer Trialists’ Collaborative Group . Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med. 1995;333(22):1444–1455
  3. Arriagada R, Rutqvist LE, Mattsson A, et al.  Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol. 1995;13(12):2869–2878
  4. Fowble B. Postmastectomy radiation (A modest benefit prevails for high risk patients). (Editorial comment) Cancer. 1997;79(6):1061–1066
  5. Hellman S. Stopping metastases at their source. (Editorial comment) N Engl J Med. 1997;337(14):996–997
  6. Olson JE, Neuberg D, Pandya KJ, et al.  The role of radiotherapy in the management of operable locally advanced breast carcinoma (Results of a randomized trial by the Eastern Cooperative Oncology Group). Cancer. 1997;79(6):1138–1149
  7. Pierce LJ, Lichter AS. Postmastectomy radiotherapy (More than locoregional control). (Editorial comment) J Clin Oncol. 1994;12(3):444–446
  8. Recht A. The return (?) of postmastectomy radiotherapy (Editorial comment). J Clin Oncol. 1995;13(12):2861–2864
  9. Overgaard M, Hansen PS, Overgaard J, et al.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337(14):949–955
  10. Overgaard M, Jensen MB, Overgaard J, et al.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen (Danish Breast Cancer Cooperative Group DBCG 82c randomised trial). Lancet. 1999;353(9165):1641–1648
  11. Ragaz J, Jackson SM, Le N, et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337(14):956–962
  12. Berger K, Fischer T, Szucs TD. Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. AEuropean perspective. Eur J Cancer. 1998;34(12):1894–1901
  13. Goodwin PJ, Shepherd FA. Economic issues in lung cancer (A review). J Clin Oncol. 1998;16(12):3900–3912
  14. Hayman JA, Hillner BE, Harris JR, et al.  Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. J Clin Oncol. 1998;16(3):1022–1029
  15. Marks LB, Hardenbergh PH, Winer ET, et al.  Assessing the cost-effectiveness of postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44(1):91–98
  16. Smith TJ, Hillner BE, Desch CE. Efficacy and cost-effectiveness of cancer treatment (Rational allocation of resources based on decision analysis). J Natl Cancer Inst. 1993;85(18):1460–1474
  17. (SBU) Swedish Council on Technology Assessment in Health Care . Cost of radiotherapy in Sweden. Acta Oncol. 1996;35(Suppl. 6):57–71
  18. Wodinsky HB, Jenkin RD. The cost of radiation treatment at an Ontario regional cancer centre. CMAJ. 1987;137(10):906–909
  19. Perez CA, Kobeissi B, Smith BD, et al.  Cost accounting in radiation oncology (A computer-based model for reimbursement). Int J Radiat Oncol Biol Phys. 1993;25(5):895–906
  20. Goddard M, Drummond M. The economic evaluation of cancer treatments and programmes. Eur J Cancer. 1991;27(10):1191–1196
  21. Hayman J, Weeks J, Mauch P. Economic analyses in health care (An introduction to the methodology with an emphasis on radiation therapy). Int J Radiat Oncol Biol Phys. 1996;35(4):827–841
  22. Valiquette L, Dunscombe P. The economic characterization of radiation treatment processes within a cancer care program. Proceedings of the 7th Canadian Conference on Health Economics, Ottawa, 1997. In press.
  23. Earle C, Coyle D, Smith A, et al.  The cost of radiotherapy atan Ontario regional cancer centre (A re-evaluation). Crit Rev Oncol Hematol. 1999;32(2):87–93
  24. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press; 1997.
  25. Dunscombe P, Roberts G, Walker J. The cost of radiotherapy as a function of facility size and hours of operation. Br J Radiol. 1999;72(858):598–603
  26. Dunscombe P, Roberts G. An economic framework for evaluating a multileaf collimator. Int J Technol Assess Health Care 2000;16(1):242–250.
  27. Inter-Society Council for Radiation Oncology . Report of the Inter-Society Council for Radiation Oncology (Radiation oncology in integrated cancer management). College Park: AAPM; 1991;
  28. Podgorsak E. Radiotherapy services in Canada (Equipment and staff workloads). Curr Oncol. 1998;5:208–215
  29. Laupacis A, Feeny D, Detsky AS, et al.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ. 1992;146(4):473–481
  30. Tengs TO, Adams ME, Pliskin JS, et al.  Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 1995;15(3):369–390
  31. Cox JD. The science and art of radiation oncology after a century. (Editorial comment) Int J Radiat Oncol Biol Phys. 1999;43(1):1–2
  32. Dunscombe P, Roberts G, Valiquette L. Outreach radiotherapy (Can it be economically viable?). (Abst.) Radiother Oncol. 1998;48:S221

PII: S0360-3016(00)00672-6

International Journal of Radiation Oncology * Biology * Physics
Volume 48, Issue 4 , Pages 977-982 , 1 November 2000